Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204152 · ClinicalTrials.gov registry record · Phase 3
Treatment for Chronic Depression
A Phase 3 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00204152 is a Phase 3 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 30 participants.
The verdict
NCT00204152, a Phase 3 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to test the clinical efficacy of two psychotherapies for early onset chronic major depression, including Behavioral Activation (Jacobson et al., 2001), and an integrated version of Behavioral Activation and Stress Innoculation Coping (BASIC) for short-term (16 weeks) of individual psychotherapy for adults with chronic major depression. The control condition is an individual workbook condition of Behavioral Activation. These psychotherapies focus on behavior activation, stress reduction and coping strategies to counter depressive symptoms.
Interventions
- BEHAVIORAL (Condition 1) Behavioral Activation; (Condition 2) Behavioral Activation and Stress Innoculation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00204152
The ClinicalTrials.gov registry entry for NCT00204152 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which (Condition 1) Behavioral Activation; (Condition 2) Behavioral Activation and Stress Innoculation is the first listed.
NCT00204152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00204152 about?
NCT00204152 is a clinical study titled "Treatment for Chronic Depression". The purpose of this study is to test the clinical efficacy of two psychotherapies for early onset chronic major depression, including Behavioral Activation (Jacobson et al., 2001), and an integrated version of Behavioral Activation and Stress Innoculation Coping (BASIC) for short-term (16 weeks) of ...
What is the current status of trial NCT00204152?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2004-06. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00204152?
The interventions under investigation include: (Condition 1) Behavioral Activation; (Condition 2) Behavioral Activation and Stress Innoculation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00204152?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.